Hemab Therapeutics Holdings, Inc. (COAG) reporting calendar
Hemab Therapeutics Holdings, Inc. files periodic reports with the SEC as COAG on Nasdaq. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 21 May 2026
- Reports on record
- 1
Open COAG market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 21 May 2026 | 51 days | 0001193125-26-234386 |
Source: SEC EDGAR company submissions for CIK 0002114044. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.